MBOT Microbot Medical Inc.
Price Chart
Executive Summary
Microbot Medical announced its first Midwest account, a healthcare system in Michigan, for its LIBERTY Endovascular Robotic System. This follows a recent North Carolina adoption and expands the company's U.S. commercial footprint into a new region. The press release provides no financial details, customer name, or order quantities.
Actionable Insight
Monitor future filings for any purchase order disclosures or recurring revenue updates from this account. The press release is a qualitative commercial milestone without quantifiable financial data — price action is likely muted until tangible revenue materializes.
Key Facts
- Secured first Midwest-based account: a healthcare system in Michigan.
- LIBERTY Endovascular Robotic System is the first FDA-cleared single-use remotely operated robotic system for peripheral endovascular procedures.
- Company recently received regulatory approval from the Israeli Ministry of Health to market the system in Israel.
- U.S. peripheral endovascular procedure market is approximately 2.5 million procedures annually per the company.
- No financial terms, purchase quantities, or revenue impact were disclosed.
Financial Impact
No financial figures disclosed; customer identity, system pricing, order volume, and revenue contribution are not provided.
Risk Factors
- No revenue contribution from this account has been disclosed; near-term financial impact may be negligible.
- Commercial adoption of a novel robotic system in new hospital accounts carries implementation and utilization risks.
- Cash burn and dilution risks remain given the company's pre-revenue or early-revenue commercial stage status.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-027861 |
| Exhibit: ex99-1.htm | 0001493152-26-027861 |
| Document: 0001493152-26-027861-index-headers.html | 0001493152-26-027861 |
| Document: 0001493152-26-027861-index.html | 0001493152-26-027861 |
| Document: 0001493152-26-027861.txt | 0001493152-26-027861 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
1d ago
|
8-K
| $1.80 awaiting T+1 | awaiting T+1 | — | $1.79 (−0.28%) |
|
Jun 2, 2026
8d ago
|
8-K
| $2.01 $1.97 | ▼ −1.99% | ▼ −1.30% | $1.79 (−10.70%) |
|
May 26, 2026
15d ago
|
8-K
| $1.81 $1.71 | ▼ −5.52% | ▼ −5.54% | $1.79 (−0.83%) |
|
May 15, 2026
26d ago
|
8-K
| $1.85 $1.78 | ▼ −3.78% | ▼ −3.72% | $1.79 (−2.97%) |
|
May 14, 2026
27d ago
|
8-K
| $1.85 $1.85 | · 0.00% | ▲ +1.23% | $1.79 (−2.97%) |
|
May 5, 2026
5w ago
|
8-K
| $2.10 $2.19 | ▲ +4.29% | ▲ +2.90% | $1.79 (−14.52%) |
|
Apr 22, 2026
7w ago
|
8-K
| $2.22 $2.18 | ▼ −1.80% | ▼ −1.41% | $1.79 (−19.14%) |
|
Apr 14, 2026
8w ago
|
8-K
| $2.43 $2.39 | ▼ −1.65% | ▼ −2.42% | $1.79 (−26.13%) |
|
Apr 13, 2026
8w ago
|
8-K
| $2.35 $2.43 | ▲ +3.40% | ▲ +2.19% | $1.79 (−23.62%) |
|
Mar 24, 2026
11w ago
|
Press Release
| $2.50 $2.53 | ▲ +1.20% | ▲ +0.63% | $1.79 (−28.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access